Xiao, X., Qian, W., Sheng, L., Wang, J., Lei, H., Li, X., Xie, J., Bao, C., Jiang, H. (2025). Orelabrutinib combined with R-CDOP regimen for first-line treatment of diffuse large B-cell lymphoma with high-risk CNS-IPI. Blood. https://doi.org/10.1182/blood-2025-5460